The Contrived Mutant p53 Oncogene – Beyond Loss of Functions

por Sabapathy, Kanaga
Publicado 2015

p73: a Positive or Negative Regulator of Angiogenesis, or Both?

por Sabapathy, Kanaga
Publicado 2016

Corrigendum: The Contrived Mutant p53 Oncogene – Beyond Loss of Functions

por Sabapathy, Kanaga
Publicado 2021

Understanding p53 functions through p53 antibodies

por Sabapathy, Kanaga, Lane, David P
Publicado 2019

Corrigendum to ‘Understanding p53 functions through p53 antibodies’

por Sabapathy, Kanaga, Lane, David P
Publicado 2019

Editorial: Multidisciplinary Approaches in Exploring Cancer Heterogeneity, TME and Therapy Resistance: Perspectives for Systems Medicine

por Pützer, Brigitte M., Sabapathy, Kanaga
Publicado 2022

Interplay between TAp73 Protein and Selected Activator Protein-1 (AP-1) Family Members Promotes AP-1 Target Gene Activation and Cellular Growth

por Subramanian, Deepa, Bunjobpol, Wilawan, Sabapathy, Kanaga
Publicado 2015

Context-dependent AMPK activation distinctly regulates TAp73 stability and transcriptional activity

por Li, Dan, Dulloo, Iqbal, Sabapathy, Kanaga
Publicado 2018

Correction to: context-dependent AMPK activation distinctly regulates TAp73 stability and transcriptional activity

por Li, Dan, Dulloo, Iqbal, Sabapathy, Kanaga
Publicado 2021

Editorial: Overcoming the cell membrane to target intracellular oncoproteins

por Brown, Christopher J., Li, Yong, Sabapathy, Kanaga
Publicado 2023

Hypoxia-induced DNp73 stabilization regulates Vegf-A expression and tumor angiogenesis similar to TAp73

por Dulloo, Iqbal, Hooi, Phang Beng, Sabapathy, Kanaga
Publicado 2015

p53-Related Transcription Targets of TAp73 in Cancer Cells—Bona Fide or Distorted Reality?

por Wang, Chao, Teo, Cui Rong, Sabapathy, Kanaga
Publicado 2020

EPLIN-β is a novel substrate of ornithine decarboxylase antizyme 1 and mediates cellular migration

por Li, Dan, Neo, Suat Peng, Gunaratne, Jayantha, Sabapathy, Kanaga
Publicado 2023

TAp73β and DNp73β activate the expression of the pro-survival caspase-2(S)

por Toh, Wen Hong, Logette, Emmanuelle, Corcos, Laurent, Sabapathy, Kanaga
Publicado 2008

Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53

por Vikhanskaya, Faina, Lee, Ming Kei, Mazzoletti, Marco, Broggini, Massimo, Sabapathy, Kanaga
Publicado 2007

Cancer therapeutic targeting using mutant–p53-specific siRNAs

por Ubby, Ifeoma, Krueger, Christian, Rosato, Roberto, Qian, Wei, Chang, Jenny, Sabapathy, Kanaga
Publicado 2019

Characterization of Novel and Uncharacterized p53 SNPs in the Chinese Population – Intron 2 SNP Co-Segregates with the Common Codon 72 Polymorphism

por Phang, Beng Hooi, Chua, Hui Wan, Li, Huihua, Linn, Yeh Ching, Sabapathy, Kanaga
Publicado 2011

C-Jun Nh(2)-Terminal Kinase (Jnk)1 and Jnk2 Have Similar and Stage-Dependent Roles in Regulating T Cell Apoptosis and Proliferation

por Sabapathy, Kanaga, Kallunki, Tuula, David, Jean-Pierre, Graef, Isabella, Karin, Michael, Wagner, Erwin F.
Publicado 2001

Functional interaction between macrophages and hepatocytes dictate the outcome of liver fibrosis

por Xie, Min, Chia, Ren Hui, Li, Dan, Teo, Fanny Xueting, Krueger, Christian, Sabapathy, Kanaga
Publicado 2021

Cancer Cells Shuttle Extracellular Vesicles Containing Oncogenic Mutant p53 Proteins to the Tumor Microenvironment

por Bhatta, Bibek, Luz, Ishai, Krueger, Christian, Teo, Fanny Xueting, Lane, David P., Sabapathy, Kanaga, Cooks, Tomer
Publicado 2021